U.S. joins whistleblower case against Insys over kickbacks

(Reuters) – The U.S. Department of Justice has joined whistleblower litigation accusing Insys Therapeutics Inc of trying to generate more profit by paying kickbacks to doctors to prescribe powerful opioid medications.

Leave a Reply

Your email address will not be published. Required fields are marked *